News
The deal gives Merck access to Verona Pharma’s new chronic obstructive pulmonary disease medication Ohtuvayre.
1 v. (various pagings) : 26 cm. +Access-restricted-item true Addeddate 2023-03-22 23:11:06 Associated-names O'Neil, Maryadele J Autocrop_version 0.0.14_books-20220331-0.2 Boxid IA40877813 Camera Sony ...
Oral delivery of potent peptide drugs provides key formulation challenges in the pharmaceutical industry: stability, solubility, and permeability. Intestinal permeation enhancers (PEs) can overcome ...
RAHWAY, N.J. - The U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) has recommended Merck’s (NYSE:MRK) ENFLONSIA as a preventive option ...
RAHWAY, N.J., June 26, 2025--ACIP Recommends Merck’s ENFLONSIA for Prevention of RSV in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season ...
Robert F. Kennedy Jr.'s revamped government panel of outside vaccine advisors on Thursday recommended the use of Merck 's shot to protect infants from respiratory syncytial virus, a temporary ...
1012 Madison Ave, Rahway, New Jersey | (732) 396-1090 # 9,796 in National Rankings Overall Score 44.51 /100 ...
The student body at the schools served by Rahway Public School District is 13.8% white, 34.8% Black, 2.7% Asian or Asian/Pacific Islander, 44.6% Hispanic/Latino, 0.3% American Indian or Alaska ...
Merck, known as MSD outside of the United States and Canada, today announced that scientific and commercial team leaders will host a virtual investor event where they will give an overview of the ...
Merck's Winrevair reduced clinical worsening in PAH patients in the Phase 3 HYPERION trial, building on prior positive study outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results